Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added related topics: Multiple myeloma and MedlinePlus Genetics in the page's resources/related topics area, providing quick access to background information. The update does not modify the trial data or eligibility criteria.
    Difference
    0.2%
    Check dated 2025-11-09T04:59:20.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    From the two screenshots, core study information (title, NCT number, study design, enrollment, and eligibility criteria) appears unchanged; only visual layout and formatting adjustments are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-02T00:51:12.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The study page no longer lists the disease 'Multiple Myeloma' and removes the related topic 'MedlinePlus Genetics' from the related topics section. This removes core content and a linked resource from the page.
    Difference
    0.2%
    Check dated 2025-10-25T21:42:43.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Multiple myeloma, expanding core genetics coverage with a specific medical condition.
    Difference
    0.2%
    Check dated 2025-10-11T15:23:34.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and confirmation that the NIH Clinical Center is open, plus a version update to v3.2.0. - Removed a MedlinePlus Genetics topic: multiple myeloma (v3.1.0) from the topics.
    Difference
    3%
    Check dated 2025-10-04T12:27:37.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Terminology updated from Plasma cell myeloma to Multiple myeloma and version bumped from v3.0.2 to v3.1.0. The change mainly reflects standard naming and versioning; no other substantive content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-27T08:08:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.